Advertisement

Topics

Evestra, Inc. and Gedeon Richter Plc. Company Profile

04:51 EDT 25th September 2018 | BioPortfolio

Gedeon Richter Plc. (www.richter.hu), headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. Richter's consolidated sales were approximately EUR 1.1 billion (USD $1.5 billion), while its market capitalization amounted to EUR 2.1 billion (USD $2.5 billion) in 2014. The product portfolio of Richter covers almost all important therapeutic areas, including gynaecology, the central nervous system and cardiovascular areas. Having the largest R&D unit in Central Eastern Europe, Richter's original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide. Richter is also active in biosimilar product development.


News Articles [49 Associated News Articles listed on BioPortfolio]

Gedeon Richter 1st-qtr sees sales and profits rising

Gedeon Richter today reported first-quarter 2018 financials, showing that consolidated sales at 113,945…

Allergan and Gedeon Richter Eye Another Indication for Bipolar Depression Drug Cariprazine

Allergan and its developmental partner Gedeon Richter Ltd. are eying an add-on approval from the U.S. Food and Drug Administration for a depression treatment based on new Phase III data released Tuesd...

Gedeon Richter Plc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 18022018] Prices from USD $350

Gedeon Richter Plc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Gedeon Richter Plc Mergers Acquisitions MA, Partnerships Alliances and Investments repo...

Gedeon Richter Plc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 26062018] Prices from USD $350

Gedeon Richter Plc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Gedeon Richter Plc Mergers Acquisitions MA, Partnerships Alliances and Investments repo...

Gedeon’s re-filed Neulasta biosimilar under EU review

European regulators have accepted a resubmission of Gedeon Richter’s biosimilar to Amgen’s Neulasta.

ESHRE 2018: GEDEON RICHTER Announces the Winners of the FORWARD Initiative - a Fertility Research Grant Dedicated to Innovative Reproductive Research

BUDAPEST, Hungary, July 2, 2018 /PRNewswire/ -- Today, GEDEON RICHTER announced the 6 winners of its 2018 FORWARD Grant initiative - a highly-competitive, fertility research grant that is dedicate...

Allergan, Richter Report Positive Topline Results From Third Cariprazine Trial

Allergan plc (AGN) and Gedeon Richter Plc announced positive topline results for RGH-MD-53, a Phase 3 study of cariprazine for the treatment of adults with major depressive episodes associated with bi...

Stada resubmits biosimilar pegfilgrastim but stops adalimumab development

German generics giant Stada Arzneimittel (Stada) was informed on 2 March 2018 by Gedeon Richter (Richter) that the European Medicines Agency (EMA) has accepted the regulatory resubmission of its propo...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Plan b [Duramed Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use Plan B safely and effectively. See full prescribing information for Plan B. Plan B (levonorgestrel) tablets, 0.75mg, for oral use Init...

Plan b one-step [Rebel Distributors Corp]

These highlights do not include all the information needed to use Plan B  One-Step safely and effectively. See full prescribing information for Plan B One-Step. Plan B One-Step (levonorgestrel) table...

Plan b one-step [Duramed Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use Plan B  One-Step safely and effectively. See full prescribing information for Plan B One-Step. Plan B One-Step (levonorgestrel) table...

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Isolated Richter's syndrome of the brain: diagnosis in the eye of the beholder.

BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.

A case report of extranodal NK/T-cell lymphoma in patient with chronic lymphocytic leukemia.

Chronic lymphocytic leukemia often results in secondary tumors, the most common being large B cell lymphoma known as Richter syndrome, followed by extranodal NK/T-cell lymphoma (nasal type) is extreme...

Earthquake prediction model using support vector regressor and hybrid neural networks.

Earthquake prediction has been a challenging research area, where a future occurrence of the devastating catastrophe is predicted. In this work, sixty seismic features are computed through employing s...

Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype and TP53 disruption.

The presence of expanded proliferation centers (PCs) in lymph nodes involved by chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has been associated with adverse clinical outcomes, bu...

Clinical Trials [14 Associated Clinical Trials listed on BioPortfolio]

Genomic and Proteomic Study of Richter Syndrome (CGPSR)

Biological study on Richter Syndrome (RS), an agressive lymphoma that arises from Chronic Lymphocytice Leukemia (CLL). RS presents with the same histological aspect as primitive Diffuse La...

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

This research study studies the combination of ibrutinib and obinutuzumab with or without the standard chemotherapy regimen of CHOP to see how well these drugs work in treating patients wi...

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome

This research study is evaluating the combination of a study drug, venetoclax, and a standard chemotherapy regimen, EPOCH-R, as a possible treatment for Richter's Syndrome. The drugs invo...

Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome

The purpose of the study is to investigate whether combination of obinutuzumab, lenalidomide, and high dose methylprednisolone in the treatment of Richter's Syndrome. The study will evalua...

Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients

Immunity and inflammation play critical roles in the pathogenesis of acute ischemic stroke. Therefore, immune intervention, as a new therapeutic strategy, is worthy of exploration. Here, i...

Companies [6 Associated Companies listed on BioPortfolio]

Evestra, Inc. and Gedeon Richter Plc.

Gedeon Richter Plc. (www.richter.hu), headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western ...

Richter-Helm BioTec GmbH & Co. KG

"Richter-Helm is a dynamic and expanding biotechnology company located in Hamburg, Germany. The company was founded in 1997 as Strathmann Biotec and was acquired by a joint-venture of Gedeon Richter P...

Evestra Inc.

Evestra Inc. is an emerging biopharmaceutical research and development company with a therapeutic focus in women’s healthcare. Evestra’s competitive advantage is based o...

Evestra, Inc.

Evestra Inc. (www.Evestra.com) is a San Antonio, Texas-based biopharmaceutical company engaged in the research and development of innovative women’s healthcare products. ...

Richter pharma AG

The past four centuries have witnessed the emergence of a globally successful pharmaceutical company from a small pharmacy facing the "Stadtplatz", the central town square of Wels.Established around 1...

More Information about "Evestra, Inc. and Gedeon Richter Plc." on BioPortfolio

We have published hundreds of Evestra, Inc. and Gedeon Richter Plc. news stories on BioPortfolio along with dozens of Evestra, Inc. and Gedeon Richter Plc. Clinical Trials and PubMed Articles about Evestra, Inc. and Gedeon Richter Plc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Evestra, Inc. and Gedeon Richter Plc. Companies in our database. You can also find out about relevant Evestra, Inc. and Gedeon Richter Plc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record